# Crohn's & Colitis Foundation

Crohn's & Colitis Foundation is a Foundation based in New York, United States.

## Overview

- **Organization type:** Foundation
- **Headquarters:** New York, United States
- **Region:** North America
- **Address:** New York, NY, United States
- **Founded:** 1967
- **Assets under management:** Undisclosed
- **Website:** crohnscolitisfoundation.org

## Regulatory record

- **Reports private funds:** No

## About

The Crohn's & Colitis Foundation is a nonprofit organization focused on curing Crohn's disease and ulcerative colitis. It offers educational programs for patients and healthcare professionals, as well as supportive services for those affected by these chronic intestinal diseases. The organization has made 5 investments, including a January 07, 2026 investment in Palisade Bio as part of their PIPE - II.

## Sectors

- Healthcare Services
- Digital Health
- Biotech
- Pharma

## Offices

- Bethesda, MD
- San Francisco, CA
- Chicago, IL
- Dallas, TX
- Atlanta, GA

## People

- Michael Osso — President & Chief Executive Officer
- Dr. Andres Hurtado-Lorenzo — Senior Vice President, Translational Research & Scientific Initiatives
- Laura Wingate — Executive Vice President, Mission

## Questions

### Who runs investment decisions at the Crohn's & Colitis Foundation?

Michael Osso serves as President and CEO, overseeing the broader organization. The venture investment decisions are guided by a scientific advisory board and the IBD Ventures team. Specific investment leads are not publicly named, but the National Scientific Advisory Committee evaluates research grants (per the foundation's website).

### How does the foundation source proprietary deal flow?

The foundation leverages its deep patient registry, IBD Plexus, and relationships with leading academic medical centers in the U.S. It also receives direct solicitations from biotech companies targeting IBD. The venture team reviews opportunities through the lens of translational potential and alignment with patient needs.

### Is the Crohn's & Colitis Foundation structured as a venture firm or a non-profit?

It is legally a 501(c)(3) non-profit organization. However, it operates a venture philanthropy program (IBD Ventures) that makes equity investments alongside grants. The foundation aims for financial returns on those investments to recycle capital into new research, distinct from a typical grant-only foundation (per public filings).

### Does the foundation participate in fund commitments or only direct investments?

The IBD Ventures program focuses on direct equity investments in early-stage companies developing IBD therapeutics, diagnostics, or digital health tools. There is no public evidence of the foundation committing capital to external venture funds.

### How is the foundation related to pharmaceutical companies?

The foundation receives corporate sponsorships and partnership funding from major pharmaceutical firms such as AbbVie, Janssen, and Takeda for patient education and research initiatives. These relationships are disclosed in annual reports but are separate from the foundation's independent venture investment decisions.

## Related profiles

- [Simeio Solutions](https://altss.com/profile/simeio-solutions)
- [Ultrastar Ventures LLC](https://altss.com/profile/ultrastar-ventures-llc)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/crohns-and-colitis-foundation

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology